Interferon-Beta

Phase 3Small molecule

Biogen

Interferon-Beta is one of 60 small molecule programs targeting Intermediate Uveitis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Intermediate UveitisActive, not recruiting

AdrenoleukodystrophyActive, not recruiting

Multiple SclerosisActive, not recruiting

COVID-19Active, not recruiting

Intermediate UveitisPhase 3

Active, not recruiting

AdrenoleukodystrophyPreclinical

Active, not recruiting

Multiple SclerosisPhase 1

Active, not recruiting

COVID-19Phase 3

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Interferon-Beta

Biogen

Phase 3

1 2

Spikevax

Moderna

Preclinical

21 3

Biaxin

AbbVie

Preclinical

2 4

Calciferol

Alnylam Pharmaceuticals

Preclinical

—5

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 6

SARS-COV-2 VACCINE

Moderna

Preclinical

2 7

Calcium

Aprotinin

1 9

Antithrombin-III

Octapharma

Preclinical

1 10

Biological Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2031

Recruiting

Pregnancy

NCT05688436

Clinical

Trials by Indication[1]

Multiple Sclerosis4 trials

Multiple Sclerosis: Chi3L1 and Treatment Efficacy

Completed·—··NCT04289675·63 enrolled

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Unknown status·FFundació Institut Germans Trias i Pujol·Phase 1·NCT02903537·16 enrolled

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Terminated· Sanofi logo

Sanofi·Phase 3·NCT01252355·534 enrolled

Show 1 more trial

A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)

Completed· EMD Serono Research & Development Institute, Inc. logo

EMD Serono Research & Development Institute, Inc.·Phase 2·NCT00436826·172 enrolled

Intermediate Uveitis1 trial

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Completed·HHeidelberg University·Phase 3·NCT00344253·19 enrolled

Adrenoleukodystrophy1 trial

Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy

Completed·FFDA Office of Orphan Products Development·N/A·NCT00004450·60 enrolled

Efficacy1 trial

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Completed·FFaron Pharmaceuticals Ltd·Phase 1/2·NCT00789685·37 enrolled

Pregnancy1 trial

A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Recruiting· Biogen logo

Biogen··NCT05688436·1,178 enrolled

2 more indications

COVID-191 trial

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Completed·PPopulation Health Research Institute·Phase 3·NCT04324463·6,667 enrolled

Unspecified1 trial

Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy

Withdrawn· Biogen logo

Biogen·Phase 4·NCT02234869

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Interferon-Beta. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Interferon-Beta compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Interferon-Beta. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Biogen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Biogen

Interferon-Beta

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2031

Trials by Indication[1]

Multiple Sclerosis4 trials

Intermediate Uveitis1 trial

Adrenoleukodystrophy1 trial

Efficacy1 trial

Pregnancy1 trial

COVID-191 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News